Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia.
Franco LocatelliJames A WhitlockChristina PetersChristiane Chen-SantelVictoria ChiaRobyn M DennisKenneth M HeymAaron J KatzMichael A KelshRichard SpostoHuakang TuCatherine A TuglusAnupam VermaLuciana VintiJennifer J WilkesNathalya ZubarovskajaGerhard ZugmaierArend von StackelbergWeili SunPublished in: Leukemia (2020)